Category: Divisions
Lack of Instruction Leads to Decreased Adherence Among Glaucoma Patients
March 16, 2015Glaucoma patients are more than twice as likely to be adherent to their medication regimen if their health-provider tells them how to use their eye drops. Patients received instruction on using their eye drops in only 14 percent of visits. Provider instruction was the only communication factor in the study that improved adherence. Physicians discussing subjects such as the disease, adherence, side effects, and effectiveness of treatment with the patient did not. Patients with glaucoma are much better at taking their medication as prescribed when a health-care provider tells them how. However, that rarely happens, according to a recent study … Read more
Jay Receives University of Kentucky Pharmaceutical Sciences Alumni Award
March 11, 2015Michael Jay, PhD, has been named the 2014 University of Kentucky Outstanding Graduate Program Alumnus for the Pharmaceutical Sciences. Jay is the Fred Eshelman Distinguished Professor and chair of the Division of Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. Jay, who received his PhD in pharmaceutical sciences at the University of Kentucky College of Pharmacy in 1980, received the award as part of the College’s annual graduate program recruitment event January 30. Jay was an assistant professor of nuclear medicine at the University of Connecticut Health Center from 1980 … Read more
Two DPET Grad Students Win ASCPT Presidential Trainee Award
March 6, 2015Akinyemi Oni-Orisan, PharmD, and Kevin Watt, MD, have been awarded a 2015 Presidential Trainee Award from the American Society for Clinical Pharmacology and Therapeutics. Oni-Orisan and Watt are PhD candidates in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. The award is given to clinical pharmacologists in training that submit the most impressive research abstract each year. Only twenty-two awardees are selected out of more than 200 submissions. Oni-Orisan and Watt were recognized at the ASCPT Annual Meeting March 3–7 in New Orleans. A New … Read more
Associate Professor Shrewsbury Publishes New Textbook on Compounding
February 19, 2015Robert Shrewsbury, PhD, has recently published the third and newest edition of his textbook on compounding, Applied Pharmaceutics and Contemporary Compounding. Shrewsbury is an associate professor in the Division of Practice Advancement and Clinical Education at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. “One of the Most Interesting Subjects” The third edition is written for pharmacy students and practitioners in pharmacy compounding. Compounding is the pharmacy specialty of making dosage forms to meet individual patient needs. It provides an alternative for patients when medications are not available in the marketplace. “Many times … Read more
Marciniak, Moose Recognized with APhA Awards
February 10, 2015Macary Marciniak, PharmD, and Joe Moose, PharmD, have both been recognized for different roles as a resource for pharmacy students by the American Pharmacists Association. Both award winners are instructors at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. Marciniak was awarded the 2015 Outstanding Chapter Adviser for her work with the Carolina Association of Pharmacy Students, and Moose was awarded the 2015 Community Pharmacy Residency Excellence in Precepting Award for his role as a preceptor at Moose Pharmacy. They will receive their award at the APhA annual meeting in San Diego, March … Read more
UNC and Duke Researchers Collaborate to Predict Drug Safety in Preemies
February 4, 2015A research duo from UNC Eshelman School of Pharmacy and Duke University has received a $50,000 grant to develop a new method for predicting drug safety in pediatric patients. The award is part of an effort by the neighboring Clinical and Translational Science Award programs to promote collaborations that translate scientific discoveries into advances in patient care. Treating Premature Patients Daniel Gonzalez, PharmD, PhD, an assistant professor in the Division of Pharmacotherapy and Experimental Therapeutics, and Christoph Hornik, MD, MPH, an assistant professor in the Duke School of Medicine, will combine their expertise in pharmaceutical sciences and pediatrics to address … Read more
Tropsha Appointed Editor of ACS Chemistry Journal
January 26, 2015Alexander Tropsha, PhD, has been appointed associate editor of the American Chemical Society’s Journal of Chemical Information and Modeling. Tropsha is the K. H. Lee Distinguished Professor in the Division of Chemical Biology and Medicinal Chemistry and the associate dean for research at the UNC Eshelman School of Pharmacy. The ACS Journal of Chemical Information and Modeling publishes papers related to new methodologies or applications in the field of chemical informatics and molecular modeling. It has an impact factor of 4.068, which means that articles published in the journal were cited an average of just over four times over a … Read more
Kabanov Elected to AIMBE College of Fellows
January 26, 2015Alexander Kabanov, PhD, DrSci, has been elected to the American Institute for Medical and Biological Engineering’s College of Fellows, an honor reserved for the top two percent of medical and biological engineers. Kabanov was nominated, reviewed, and elected by peers and members of the College of Fellows for seminal works on polymeric nanosystems for drug delivery that have considerably influenced current ideas and approaches in nanomedicine, according to AIMBE. Kabanov is the Mescal Swaim Ferguson Distinguished Professor in the Division of Chemical Biology and Medicinal Chemistry at the UNC Eshelman School of Pharmacy and director of the School’s Center for Nanotechnology in … Read more
Associate Professor Federico Innocenti Granted Tenure
January 20, 2015Federico Innocenti, MD, PHD, an associate professor at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill, has been granted tenure. He is associate director of the School’s Center for Pharmacogenomics and Individualized Therapy. Genes and Cancer Innocenti’s NIH-funded research program focuses on the search for genetic variations in patients that determine the efficacy and toxicity of cancer therapy. One of Innocenti’s notable research achievements is the discovery of the genetic basis for the neutropenia — or severe shortage of certain white blood cells — experienced by some patients being treated with the cancer … Read more
Tumor Microenvironment Is a Rough Neighborhood for Nanoparticle Drugs
January 13, 2015Researchers compared the amount of doxorubicin and its nanoparticle counterpart, Doxil, delivered to two tumor models of triple-negative breast cancer. Both tumors received much more Doxil than doxorubicin, which was expected. But one type of tumor received twice as much Doxil as the other, surprising the researchers. Doxil is a drug made up of nanoparticles that contain approximately 10,000 of molecules of doxorubicin. Nanoparticle drugs—tiny containers packed with medicine and with the potential to be shipped straight to tumors—were thought to be a possible silver bullet against cancer. However, new cancer drugs based on nanoparticles have not improved overall survival … Read more